Influense of the effect of experimental diabetes mellitus on the protein expression of apoptotic regulators Bcl-2 and p53 in the lymphoid follicles of the spleen.

Authors

  • I. Grinevich Zaporizhzhia State Medical University, Ukraine
  • A. Kamyshny Zaporizhzhia State Medical University, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2010.4.19-23

Keywords:

spleen, diabetes mellitus, Bcl-2, p53

Abstract

The problem of investigation of molecular mechanisms of apoptosis and its role in autoimmune disease, including diabetes mellitus, became one of the most difficult and actual among the medical sciences last years. Under the experiment the effect of experimental diabetes mellitus on the intensity of protein expression of apoptotic regulators Bcl-2 and p53 in the spleen of rats was investigated. To detect Bcl-2 and p53 positive-cells we used immunohistochemical technique of indirect immunofluorescence with monoclonal antibodies to Bcl-2 and p53. It was found that the development of experimental diabetes mellitus is accompanied by unidirectional tendency to increase the number of p53- and Bcl-2-positive cells in lymphoid follicles of the spleen with a preferential decrease in the concentration of these protein in immune cells.

References

  1. Барышников А. Ю. Иммунологические проблемы апоптоза / А. Ю. Барышников, Ю. В. Шишкин. - М. : Эдиториал УРСС, 2002. – 320 с.
  2. Фильченков А. А. Апоптоз и рак / А. А. Фильченков, Р. С. Стойка. - М. : Морион, 1999. – 184 с.
  3. Ярилин А. А. Апоптоз и его место в иммунных процессах / А. А. Ярилин // Иммунология. - 1996. - № 6. – С. 10–22.
  4. Ярилин А. А. Апоптоз: природа феномена и его роль в норме и при патологии / А. А. Ярилин // Актуальные проблемы патофизиологии. - М. : Медицина, 2001. - С. 13–56.
  5. Harris S. The p53 pathway: positive and negative feedback loops / S. Harris, A. Levine // Onco-gene. - 2005. - Vol. 24. - P. 2899–2908.
  6. Jänicke R. The dark side of a tumor suppressor: anti-apoptotic p53 / R. Jänicke, D. Sohn, K. Schulze-Osthoff // Cell Death Differ. – 2008. – Vol. 15, № 6. – Р. 959-976.
  7. Lavin M. The complexity of p53 stabilization and activation / M. Lavin, N. Gueven // Cell Death and Differentiation. - 2006. - Vol. 13. - P. 941–950.
  8. Levine A. The p53 pathway: what questions remain to be explored? / A. Levine, W. Hu, Z. Feng // Cell Death and Differentiation. - 2006. - Vol. 13. - P. 1027–1036.
  9. Opferman J. Apoptosis in the development and maintenance of the immune system / J. Opferman, S. Korsmeyer // Nat. Immunol. – 2003. – Vol. 4. – P. 410–415.
  10. Orduño N. M. B cells and immunological tolerance / Nataly Manjarrez Orduño, Tam Quach, Iñaki Sanz1 // J. Invest. Dermatol. – 2009. – Vol. 129, № 2. – Р. 278–288.
  11. Oren M. Decision making by p53: life, death and cancer / M. Oren // Cell Death Differ. - 2003. - Vol. 10. - P. 431–442.
  12. Vousden K. Outcomes of p53 activation – spoilt for choice / K. Vousden // J. Cell. Sci. - 2006. - Vol. 119. - P. 5015–5020.
  13. Zhang N. The role of apoptosis in the development and function of T lymphocytes / N. Zhang, Н. Hartig, I. Dzhagalov [et al.] // Cell Res. – 2005. –№ 10. – P. 749–769.

How to Cite

Grinevich, I., & Kamyshny, A. (2010). Influense of the effect of experimental diabetes mellitus on the protein expression of apoptotic regulators Bcl-2 and p53 in the lymphoid follicles of the spleen. Морфологія / Morphologia / Morfologìâ, 4(4), 19–23. https://doi.org/10.26641/1997-9665.2010.4.19-23

Issue

Section

Статті